InferVision

AI solutions intended for disease screening, intervention and treatment, patient management and medical research for full-hospital deployment serving physicians.

Book a meeting

Company Overview

Established in 2016, Infervision focuses on the AI healthcare domain, driven by the mission of “Improving Lives and Health through AI.” The company is dedicated to becoming a leading international brand in AI across the entire healthcare spectrum. Utilizing AI deep learning technology, the company develops solutions to provide customers with a comprehensive “screening, diagnose, treatment, management, research” solution throughout the medical process.

Infervision is regulatory cleared in China, the United States, the European Union, and Japan. Its products are utilized in over 400 medical institutions across nearly 20 countries worldwide.

Infervision provides advanced integrated smart healthcare services to medical institutions, doctors, and patients alike.

Infervision cut

Modalities

MRI-icon-2-150x150

Subspecialities

Thoracic icon

Applications available

Infervision cut

InferREAD Lung CT.AI

Computer assisted reading tools designed to aid radiologists in the detection of pulmonary nodules on chest CT scans.

CE

FDA

CT

Pulmonology

To find out more about InferVision’s solutions, or the 100+ other applications on the Blackford Platform, book a discovery call with our team.

review image 1

Book a meeting

We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.

Book a Meeting